Select Page
Expert Discussion - ViroChannel

For more than 20 years, the Clinique médicale l’Actuel, under the medical direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

Hepatitis C

with Dr. Emmanuelle Huchet and Dr. Marc Poliquin



  • The recent arrival of new treatments against hepatitis C
  • The new challenges faced by physicians treating hepatitis-C infected patients
  • Treatments to come in a near future
  • Hope for a cure

This activity is supported by
an educational grant from:




In this program, Dr. Emmanuelle Huchet sits down with Dr. Marc Poliquin, gastro-hepatologist at Clinique médicale l’Actuel and Verdun Hospital, to discuss hepatitis C treatment.

Dr. Poliquin explains the benefits of the new, recently arrived treatments and of the ones to come. During this interview, Dr. Poliquin discusses the changing landscape in the treatment of hepatitis C and the new found hope of being able to completely cure patients infected by this virus.

Emmanuelle Huchet, MD

Emmanuelle Huchet, MD


Clinique médicale l’Actuel:
Centre of Excellence HIV–STI–Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

Marc Poliquin, MD

Marc Poliquin, MD


Gastroenterologist, Hepatologist
Verdun Hospital
Clinique médicale l’Actuel:
Centre of Excellence HIV–STI–Hepatitis
Montréal, Québec, Canada


Only Logged in users can see the full program

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Emmanuelle Huchet, MD has a financial interest/relationship or affiliation in the form of:
Consultant: AbbVie, Bristol-Myers Squibb, Janssen, Gilead, Merck, ViiV Healthcare.

Marc Poliquin, MD has a financial interest/relationship or affiliation in the form of:
Consultant:  AbbVie, Janssen, Merck, Roche, Vertex and Advisory board member for Gilead.

Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.